In 2017 Bastani et al. assessed the diagnostic value of serum markers (prostasin, CA125, LDH, AFP, hCG + β) in epithelial ovarian cancer (EOC) and their potential for distinguishing EOC from benign tumors and healthy individuals. The gene discussed is MUC16; the disease is benign neoplasm.